Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
R. Böcskei (Budapest, Hungary), B. Benczúr (Szekszárd, Hungary), A. Bikov (Budapest, Hungary), C. Böcskei (Tatabánya, Hungary), A. Bohács (Budapest, Hungary), V. Müller (Budapest, Hungary). Cardiovascular risk detection in COPD. 5016

Member's Comments

No comment yet.

Related content which might interest you: Cardiovascular disease in COPD Source: Eur Respir Monogr 2020; 88: 47-65 Year: 2020 Cardiovascular risk and exercise capacity in COPD Source: International Congress 2018 – Additional latest insights in pulmonary rehabilitation for chronic lung diseases Year: 2018 Cardiovascular risk assessment in COPD patients with severe exacerbation Source: International Congress 2016 – Comorbidities and exacerbations in COPD Year: 2016 Global cardiovascular disease risk in U.S. adults by severity and presence of COPD Source: Annual Congress 2010 - Comorbidity in obstructive airway disease Year: 2010 Chronic asthma and the risk of cardiovascular disease Source: Eur Respir Monogr 2020; 88: 82-95 Year: 2020 Cardiovascular comorbidities in hospitalised COPD patients: a determinant of future risk? Source: Eur Respir J 2015; 46: 846-849 Year: 2015 Exacerbations and mortality of COPD patients with cardiovascular disease in the UK Source: Annual Congress 2010 - Comorbidity in obstructive airway disease Year: 2010 Comparing non-invasive cardiovascular risk assessment tools in COPD patients: Validation with CV events Source: International Congress 2014 – Respiratory disease within hospital-based populations Year: 2014 Modifiable risk factors for all-cause hospitalization in obstructive lung disease Source: International Congress 2015 – Risk factors and co-morbidities in asthma and COPD Year: 2015 Prevalence of cardiovascular disease in COPD patients in the UK Source: Annual Congress 2010 - Comorbidity in obstructive airway disease Year: 2010 Microalbuminuria as a cardiovascular biomarker in patients with COPD Source: International Congress 2016 – Systemic biomarkers Year: 2016 Cardiovascular comorbidity in severe COPD patients Source: International Congress 2017 – Markers of COPD progression Year: 2017 Frequency of occurrence of risk factors of cardiovascular diseases and assessment of the total cardiovascular risk in patients with chronic obstructive pulmonary disease (COPD). Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD Year: 2019 Correlates and assessment of excess cardiovascular risk in bronchiectasis Source: Eur Respir J, 50 (5) 1701127; 10.1183/13993003.01127-2017 Year: 2017 Screening for the risk of malnutrition in COPD patients Source: Annual Congress 2008 - Impact of nursing interventions on the quality of care for COPD patients Year: 2008 Cardiovascular comorbidities of COPD in never-smokers Source: International Congress 2014 – Highlights in respiratory epidemiology Year: 2014 Burden of obstructive lung disease study in Tehran: Prevalence and risk factors of COPD Source: International Congress 2015 – Management of COPD and other respiratory diseases in primary care Year: 2015